Literature DB >> 29761149

How SpyGlass™ May Impact Endoscopic Retrograde Cholangiopancreatography Practice and Patient Management.

Pedro Pereira1, Filipe Vilas-Boas1, Armando Peixoto1, Patrícia Andrade1, Joanne Lopes1, Guilherme Macedo1.   

Abstract

INTRODUCTION: Cholangiopancreatoscopy with SpyGlass™ Direct Visualization System (SGDVS) is being used in specialized centers for improving the sensitivity of endoscopic retrograde cholangiopancreatography (ERCP) in patients with indeterminate pancreatobiliary strictures (PBS). The aims of this study were to report our initial experience with SGDVS in the evaluation of indeterminate PBS, and discuss the improvements of ERCP brought by this technique in our center.
METHODS: The usefulness of SGDVS in patients with indeterminate PBS (defined after nondiagnostic previous ERCP with brush cytology) was evaluated in a prospective observational cohort study conducted at a single tertiary biliopancreatic unit. The accuracy of diagnosis by the SGDVS visual findings, SGDVS-guided biopsy, technical success, image quality, change in patient management after the procedure, and complication rate were assessed.
RESULTS: In our single-center cohort, there were 13 SGDVS procedures for evaluating indeterminate PBS. Technical success, defined by the ability to progress with the SpyScope to the target lesion, was achieved in all the cases. The diagnostic accuracy of visual findings (87.5%) was superior to SGDVS-guided biopsy (55%). In 11 (85%) procedures, the image quality was considered good. The procedure permitted exclusion of malignancy and avoiding surgery in 9 patients (69%). There were no complications during the procedures. However, in the post-procedure monitoring, 3 patients developed acute pancreatitis (19%) and 2 patients developed acute cholangitis (13%).
CONCLUSION: The SGDVS can be considered useful in the context of indeterminate PBS. The intervention is associated with high procedural success and alters clinical outcome compared to conventional approaches.

Entities:  

Keywords:  Biliary stricture; Cholangioscopy; Endoscopic retrograde cholangiopancreatography; Pancreatoscopy

Year:  2017        PMID: 29761149      PMCID: PMC5939843          DOI: 10.1159/000481859

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


  19 in total

1.  ERCP with cholangiopancreatoscopy may be associated with higher rates of complications than ERCP alone: a single-center experience.

Authors:  Amrita Sethi; Yang K Chen; Gregory L Austin; William R Brown; Brian C Brauer; Norio N Fukami; Abdul H Khan; Raj J Shah
Journal:  Gastrointest Endosc       Date:  2010-11-24       Impact factor: 9.427

2.  Role of single-operator peroral cholangioscopy in the diagnosis of indeterminate biliary lesions: a single-center, prospective study.

Authors:  Mohan Ramchandani; D Nageshwar Reddy; Rajesh Gupta; Sandeep Lakhtakia; Manu Tandan; Santosh Darisetty; Anuradha Sekaran; Guduru Venkat Rao
Journal:  Gastrointest Endosc       Date:  2011-07-07       Impact factor: 9.427

3.  Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos).

Authors:  Yang K Chen; Mansour A Parsi; Kenneth F Binmoeller; Robert H Hawes; Douglas K Pleskow; Adam Slivka; Oleh Haluszka; Bret T Petersen; Stuart Sherman; Jacques Devière; Søren Meisner; Peter D Stevens; Guido Costamagna; Thierry Ponchon; Joyce A Peetermans; Horst Neuhaus
Journal:  Gastrointest Endosc       Date:  2011-07-18       Impact factor: 9.427

4.  SpyGlass single-operator peroral cholangioscopy in the evaluation of indeterminate biliary lesions: a single-center, prospective, cohort study.

Authors:  Raffaele Manta; Marzio Frazzoni; Rita Conigliaro; Livia Maccio; Gianlugi Melotti; Emanuele Dabizzi; Helga Bertani; Mauro Manno; Danilo Castellani; Vincenzo Villanacci; Gabrio Bassotti
Journal:  Surg Endosc       Date:  2012-12-12       Impact factor: 4.584

5.  Role of SpyGlass peroral cholangioscopy in the evaluation of indeterminate biliary lesions.

Authors:  Young Sik Woo; Jong Kyun Lee; Se Hun Oh; Min Jung Kim; Jae Gu Jung; Kwang Hyuck Lee; Kyu Taek Lee
Journal:  Dig Dis Sci       Date:  2014-05-01       Impact factor: 3.199

6.  Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  Basile Njei; Thomas R McCarty; Shyam Varadarajulu; Udayakumar Navaneethan
Journal:  Gastrointest Endosc       Date:  2016-08-30       Impact factor: 9.427

Review 7.  Sensitivity of alternative testing for pancreaticobiliary cancer: a 10-y review of the literature.

Authors:  Atuhani S Burnett; Joanelle Bailey; Joseph B Oliver; Sushil Ahlawat; Ravi J Chokshi
Journal:  J Surg Res       Date:  2014-04-13       Impact factor: 2.192

8.  Patients with obstructive jaundice and biliary stricture ± mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA.

Authors:  Pavan Tummala; Satish Munigala; Mohamad A Eloubeidi; Banke Agarwal
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

Review 9.  Management of hilar biliary strictures.

Authors:  Alberto Larghi; Andrea Tringali; Piera G Lecca; Marco Giordano; Guido Costamagna
Journal:  Am J Gastroenterol       Date:  2007-11-19       Impact factor: 10.864

Review 10.  Sensitivity of endoscopic retrograde cholangiopancreatography standard cytology: 10-y review of the literature.

Authors:  Atuhani S Burnett; Thomas J Calvert; Ravi J Chokshi
Journal:  J Surg Res       Date:  2013-07-05       Impact factor: 2.192

View more
  2 in total

Review 1.  Indications for Single-Operator Cholangioscopy and Pancreatoscopy: an Expert Review.

Authors:  Enrique Pérez-Cuadrado-Robles; Pierre H Deprez
Journal:  Curr Treat Options Gastroenterol       Date:  2019-09

2.  Outcomes of Single-Operator Cholangioscopy-Guided Lithotripsy in Patients with Difficult Biliary and Pancreatic Stones.

Authors:  Jorge Canena; Luís Lopes; João Fernandes; Gonçalo Alexandrino; Luís Lourenço; Diogo Libânio; David Horta; Sílvia Giestas; Jorge Reis
Journal:  GE Port J Gastroenterol       Date:  2018-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.